Antihypertensive and antiproteinuric efficacy of ramiprilin children with chronic renal failure
- 1 August 2004
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 66 (2), 768-776
- https://doi.org/10.1111/j.1523-1755.2004.00802.x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Ethics of Placebo Use in Pediatric Clinical TrialsHypertension, 2003
- Angiotensin-Converting Enzyme Inhibitors and Progression of Nondiabetic Renal DiseaseAnnals of Internal Medicine, 2001
- Chronic proteinuric nephropathies: Outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injuryAmerican Journal of Kidney Diseases, 2000
- Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathyThe Lancet, 1997
- Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: A multicenter trial including 1141 subjectsThe Journal of Pediatrics, 1997
- Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal InsufficiencyNew England Journal of Medicine, 1996
- The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic NephropathyNew England Journal of Medicine, 1993
- Effect of Enalapril on the Progression of Chronic Renal FailureAmerican Journal of Hypertension, 1992
- The Use of Plasma Creatinine Concentration for Estimating Glomerular Filtration Rate in Infants, Children, and AdolescentsPediatric Clinics of North America, 1987
- EARLY AGGRESSIVE ANTIHYPERTENSIVE TREATMENT REDUCES RATE OF DECLINE IN KIDNEY FUNCTION IN DIABETIC NEPHROPATHYThe Lancet, 1983